AVMA news
Monoclonal antibodies show promise as new therapy for veterinary patients
More than 100 monoclonal antibodies (mAb) designed to bind to specific target proteins are available for humans, including those intended to treat…
AVMA news
FDA creates guidance on informed consent for companion animal studies
The U.S. Food and Drug Administration (FDA) has announced draft guidance that will help animal owners who are considering having their companion…
AVMA news
Shortage of cancer drugs having devastating effects on patients, veterinarians
Chemotherapy drugs, including cisplatin and carboplatin, have been in short supply for months. The situation is affecting animal patients and…
AVMA news
FDA proposes framework for collecting antimicrobial use data
The Food and Drug Administration’s Center for Veterinary Medicine is inviting public comment on a possible framework for establishing a public-private…
AVMA news
Claims about meat, poultry products come under greater USDA scrutiny
The U.S. Department of Agriculture is stepping up efforts to ensure the veracity of claims about food animal products marketed as "free range" and…
AVMA news
A research facility ahead of its time
The state-of-the-art National Bio and Agro-Defense Facility, based in the nation’s heartland, is arguably the most advanced animal agriculture…
AVMA news
EPA confirms registration, safety of Seresto collar
The U.S. Environmental Protection Agency (EPA) confirmed the registration and affirmed the safety profile of the Seresto flea and tick collar after a…
AVMA news
USDA funds antimicrobial resistance dashboard research
The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service has awarded more than $3.2 million to several universities to develop…
AVMA news
Four veterinary scientists recognized with AVMA research awards
The AVMA honored Drs. Jim E. Riviere, Nicholas (Nick) Jeffery, Natasha Olby, and Boaz Arzi with 2023 AVMA Excellence Awards for contributions to…
AVMA news
AVMF, VPRF announce veterinary pharmacology fellowship grant
The American Veterinary Medical Foundation (AVMF) and the Veterinary Pharmacology Research Foundation (VPRF) have partnered to fund a one-year…
AVMA news
House Committee advances AVMA-backed xylazine language
The Administration announced its national coordinated response on July 11 to fight the deadly combination of illicit xylazine mixed with fentanyl.
AVMA news
Marijuana, other recreational drugs debut on pet toxins top 10 list
The American Society for the Prevention of Cruelty to Animals (ASPCA) Animal Poison Control Center (APCC) announced its annual list of top toxins for…
AVMA news
Canine parvovirus treatment receives conditional approval
The U.S. Department of Agriculture has granted a conditional license for the Canine Parvovirus Monoclonal Antibody—Elanco's first monoclonal antibody…
AVMA news
Map shows heartworm rates continue to increase in hot spots, new locations
According to the recently released 2022 American Heartworm Society (AHS) Heartworm Incidence Map, rates have continued to trend upward in both…
AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
AVMA news
Illicit xylazine, fentanyl combination decreed ‘emerging threat’
The Biden administration designated fentanyl combined with xylazine as an “emerging threat” to the U.S. on April 12, which will allow the federal…
AVMA news
Zoetis receives $15.3M grant to improve livestock health in Africa
Zoetis announced in March that the company received a $15.3 million grant from the Bill & Melinda Gates Foundation to further develop and integrate…
AVMA news
New law clarifies alternatives to animal testing for safety, efficacy of drugs
The recently passed FDA Modernization Act 2.0 authorizes the use of certain alternatives to animal testing, including cell-based assays and computer…
AVMA news
Multiple vaccine candidates in the works for African swine fever
For years, researchers have been working to develop a safe, effective, and commercially available vaccine for African swine fever as it continues to…
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…